What is it about?
The purpose of this review was to illustrate changes in how cystic fibrosis patients are diagnosed and managed, as well as more detailed information on laboratory aspects. This includes some history and background, as well as the current status of testing a treatment.
Featured Image
Why is it important?
The recent changes to the interpreting sweat chloride values as well as the implementation of new pharmacological agents is changing how cystic fibrosis is diagnosed and treated. It's important for all care providers to understand these changes in order to provide consistent and proper care for this patient population.
Perspectives
There are many nuances to the diagnosis of cystic fibrosis. Changes have occurred due to advances in newborn screening, genetic testing and clinical correlation to sweat chloride values. It's critical that those who provide these services are standardized. Many adult facilities are not intimately familiar with these details, so the paper is a wonderful resource for all individuals interested in learning about cystic fibrosis.
Stanley Lo
Medical College of Wisconsin
Read the Original
This page is a summary of: Advances in the Diagnosis and Management of Cystic Fibrosis in the Genomic Era, Clinical Chemistry, February 2018, AACC,
DOI: 10.1373/clinchem.2017.274670.
You can read the full text:
Contributors
The following have contributed to this page
